Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease
NCT05196958
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Diabetes Mellitus, Type 2
Interventions
OTHER:
GLP1 analogues
Sponsor
Fondation Hôpital Saint-Joseph